Clinical Trial Update: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neoadjuvant chemotherapy with trastuzumab and pertuzumab in HER2-negative breast cancer patients with abnormal HER2 signaling is ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• chemotherapy regimens typical in neoadjuvant settings

Snippet

Sponsor: NSABP Foundation Inc | Conditions: HER2-negative Breast Cancer | Phase 2 | Status: UNKNOWN